Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Pierluigi Viale and Michele Bartoletti.
Connection Strength

8.929
  1. Clinical experience with therapeutic dose of Low-Molecular-Weight Heparin. Infez Med. 2020 Jun 01; 28(suppl 1):118-121.
    View in: PubMed
    Score: 0.885
  2. The role of extended infusion ß-lactams in the treatment of bloodstream infections in patients with liver cirrhosis. Expert Rev Anti Infect Ther. 2018 10; 16(10):771-779.
    View in: PubMed
    Score: 0.788
  3. Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients. Infect Dis Clin North Am. 2018 09; 32(3):551-580.
    View in: PubMed
    Score: 0.784
  4. Opportunistic infections in end stage liver disease. Infect Dis Rep. 2018 Mar 29; 10(1):7621.
    View in: PubMed
    Score: 0.761
  5. Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections. Int J Antimicrob Agents. 2018 Mar; 51(3):516-521.
    View in: PubMed
    Score: 0.753
  6. Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment. Transpl Infect Dis. 2017 Apr; 19(2).
    View in: PubMed
    Score: 0.708
  7. Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: a case series. BMC Res Notes. 2014 Jan 13; 7:32.
    View in: PubMed
    Score: 0.569
  8. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study. Clin Infect Dis. 2021 12 06; 73(11):e3606-e3614.
    View in: PubMed
    Score: 0.246
  9. How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre. Eur J Endocrinol. 2020 Oct; 183(4):389-397.
    View in: PubMed
    Score: 0.226
  10. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study. Clin Microbiol Infect. 2021 Jan; 27(1):105-111.
    View in: PubMed
    Score: 0.226
  11. Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study). Clin Microbiol Infect. 2020 Nov; 26(11):1545-1553.
    View in: PubMed
    Score: 0.224
  12. Clinical Impact of Renin-angiotensin System Inhibitors on In-hospital Mortality of Patients With Hypertension Hospitalized for Coronavirus Disease 2019. Clin Infect Dis. 2020 07 28; 71(15):899-901.
    View in: PubMed
    Score: 0.224
  13. Extended Infusion of ß-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study. Clin Infect Dis. 2019 10 30; 69(10):1731-1739.
    View in: PubMed
    Score: 0.212
  14. Risk factors for treatment failure in patients receiving ß-lactam/ß-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study. Int J Antimicrob Agents. 2019 May; 53(5):574-581.
    View in: PubMed
    Score: 0.201
  15. Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study. J Antimicrob Chemother. 2018 10 01; 73(10):2856-2859.
    View in: PubMed
    Score: 0.197
  16. Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection. Transpl Infect Dis. 2018 Oct; 20(5):e12930.
    View in: PubMed
    Score: 0.193
  17. Treatment duration for Escherichia coli bloodstream infection and outcomes: retrospective single-centre study. Clin Microbiol Infect. 2018 Oct; 24(10):1077-1083.
    View in: PubMed
    Score: 0.188
  18. Infectious Diseases Team for the Early Management of Severe Sepsis and Septic Shock in the Emergency Department. Clin Infect Dis. 2017 10 15; 65(8):1253-1259.
    View in: PubMed
    Score: 0.184
  19. A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients. Clin Microbiol Infect. 2018 May; 24(5):546.e1-546.e8.
    View in: PubMed
    Score: 0.182
  20. Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study. Eur J Clin Microbiol Infect Dis. 2017 Oct; 36(10):1965-1970.
    View in: PubMed
    Score: 0.180
  21. Superficial swab versus deep-tissue biopsy for the microbiological diagnosis of local infection in advanced-stage pressure ulcers of spinal-cord-injured patients: a prospective study. Clin Microbiol Infect. 2017 Dec; 23(12):943-947.
    View in: PubMed
    Score: 0.178
  22. The Gut Microbiota of Critically Ill Patients With COVID-19. Front Cell Infect Microbiol. 2021; 11:670424.
    View in: PubMed
    Score: 0.060
  23. The lower respiratory tract microbiome of critically ill patients with COVID-19. Sci Rep. 2021 05 12; 11(1):10103.
    View in: PubMed
    Score: 0.059
  24. Hospital-Acquired Infections in Critically Ill Patients With COVID-19. Chest. 2021 08; 160(2):454-465.
    View in: PubMed
    Score: 0.059
  25. Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study. Infect Control Hosp Epidemiol. 2021 Apr 16; 1-6.
    View in: PubMed
    Score: 0.059
  26. Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
    View in: PubMed
    Score: 0.058
  27. Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study. J Clin Med. 2021 Feb 03; 10(4).
    View in: PubMed
    Score: 0.058
  28. Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations. J Glob Antimicrob Resist. 2021 03; 24:124-126.
    View in: PubMed
    Score: 0.058
  29. Use of critical care resources during the first 2 weeks (February 24-March 8, 2020) of the Covid-19 outbreak in Italy. Ann Intensive Care. 2020 Oct 12; 10(1):133.
    View in: PubMed
    Score: 0.057
  30. Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients. Front Pharmacol. 2020; 11:1124.
    View in: PubMed
    Score: 0.056
  31. COVID-19 in solid organ transplant recipients: No difference in survival compared to general population. Transpl Infect Dis. 2021 Feb; 23(1):e13421.
    View in: PubMed
    Score: 0.056
  32. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e474-e484.
    View in: PubMed
    Score: 0.056
  33. Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study. J Infect. 2019 08; 79(2):130-138.
    View in: PubMed
    Score: 0.052
  34. Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections. Gut. 2018 10; 67(10):1892-1899.
    View in: PubMed
    Score: 0.046
  35. Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection. Int J Antimicrob Agents. 2018 Feb; 51(2):244-248.
    View in: PubMed
    Score: 0.046
  36. Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy. Eur J Intern Med. 2016 Oct; 34:39-44.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.